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Background: Integrated care can generate health and social care efficiencies through the defragmentation of care and adoption
of patient-centered preventive models. eHealth can be a key enabling technology for integrated care.
Objective: The aim of this study was to assess the effectiveness and cost-effectiveness of the implementation of a mobile health
(mHealth)-enabled integrated care model for complex chronic patients.
Methods: As part of the CONNECARE Horizon 2020 project, a prospective, pragmatic, two-arm, parallel implementation trial
was held in a rural region of Catalonia, Spain. During 3 months, elderly patients with chronic obstructive pulmonary disease or
heart failure and their carers experienced the combined benefits of the CONNECARE organizational integrated care model and
the eHealth platform supporting it, consisting of a patient self-management app, a set of integrated sensors, and a web-based
platform connecting professionals from different settings, or usual care. We assessed changes in health status with the 12-Item
Short-Form Survey (SF-12), unplanned visits and admissions during a 6-month follow up, and the incremental cost-effectiveness
ratio (ICER).
Results: A total of 48 patients were included in the integrated care arm and 28 patients receiving usual care were included in
the control arm (mean age 82 years, SD 7 years; mean Charlson index 7, SD 2). Integrated care patients showed a significant
increase in the SF-12 physical domain with a mean change of +3.7 (SD 8.4) (P=.004) and total SF-12 score with a mean change
of +5.8 (SD 12.8) (P=.003); however, the differences in differences between groups were not statistically significant. Integrated
care patients had 57% less unplanned visits (P=.004) and 50% less hospital admissions related to their main chronic diseases
(P=.32). The integrated care program generated savings in different cost scenarios and the ICER demonstrated the cost-effectiveness
of the program.
Conclusions: The implementation of a patient-centered mHealth-enabled integrated care model empowering the patient, and
connecting primary, hospital, and social care professionals reduced unplanned contacts with the health system and health costs,
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and was cost-effective. These findings support the notion of system-wide cross-organizational care pathways supported by mHealth
as a successful way to implement integrated care.
(JMIR Mhealth Uhealth 2021;9(1):e22135) doi: 10.2196/22135
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Introduction
The last decades have led to rapidly aging populations and an
increased burden of chronic diseases [1]. In this scenario, health
and social care providers struggle to contain costs while
providing an adequate response to the population’s care needs.
Traditional care models suffer from care fragmentation. That
is, the different care settings fail to communicate with each
other effectively, and patients have to undergo repeated tests
and changes in prescribed drugs, ultimately prompting feelings
of starting anew after every transition [2]. Additionally, the
focus is still on the diseases rather than on the patients, which
leaves patients and their carers as passive actors [2]. Therefore,
there is a need for a profound redesign of how care is provided
to elderly patients with chronic conditions to ensure quality and
sustainability [3]. Integrated care models aim to generate health
and social care efficiencies through the defragmentation of care,
promotion of collaboration and continuity of care across settings,
adoption of patient-centered models, and prioritization of
preventive models [4]. However, few of these models have
attempted to and succeeded in simultaneously tackling all of
the above-mentioned measures [4]. eHealth and mobile health
(mHealth) can be the key enabling technologies allowing for
such a paradigm shift [5].
The Personalised Connected Care for Complex Chronic Patients
(CONNECARE) project is a Horizon 2020 European Union
Research and Innovation project aiming to co-design, develop,
deploy, and evaluate a novel smart and adaptive organizational
integrated care model for complex chronic patients (CCP) [6].
From April 2016 to December 2019, the project successfully
co-designed, by means of an iterative patient-centered process
involving patients and stakeholders across different health
settings, an organizational model for integrated care and an
eHealth platform to support the model. The integrated care
model promotes collaboration among professionals of different
care settings (family physicians, hospital specialists, and social
workers), prioritizes home-based prevention over institutional
reactive care, and fosters patient empowerment. The use of a
web-based platform offers a cross-setting web-based Smart
Adaptive Case Management (SACM) system for professionals,
and an mHealth self-management system with three-level
monitoring features allowing for patient empowerment.
As part of the CONNECARE project, a novel mHealth-enabled
integrated care model was implemented in Lleida, Spain. The
existing care model in Lleida is limited by the scarce
communication between professionals of different care settings,
with different electronic medical record (EMR) systems in
hospitals and primary care centers (Argos SAP and ECAP [7],
respectively), and patients playing a passive role throughout
the care path. We here describe the results of the implementation
of an mHealth-enabled integrated care model for the
community-based prevention of unplanned hospital-related
events in CCP with a high risk for hospitalization.
Methods
Study Design
This was a prospective, pragmatic, two-arm, parallel
implementation trial comparing care as usual to a 3-month
mHealth-enabled integrated care intervention. The study was
conducted from July 2018 to August 2019 in Lleida, which is
a large rural area of over 4300 km2, including two tertiary
hospitals (University Hospital Arnau de Vilanova and University
Hospital Santa Maria) and a network of 23 primary care centers
spread across the whole territory, providing service to 400,000
citizens.
Target Population
Home-dwelling patients with chronic conditions and a history
of hospitalizations were recruited for this study. The eligibility
criteria were aged ≥55 years; admitted to hospital for a
respiratory or cardiovascular event (ie, chronic obstructive
pulmonary disease exacerbation or heart failure
decompensation); living at home and discharged back to the
community; no dementia or cognitive impairment (Global
Deterioration Scale score < 5 [8]); Length, Acuity,
Comorbidities and Emergency score > 7 [9]; and passing a basic
technological test assessing home connectivity and patients’ or
carers’ competences with the use of technology. The basic
technological test is shown in Multimedia Appendix 1.
Recruitment
Patients were recruited during an unanticipated admission to
the hospital through the emergency room (ER). They were
identified based on EMR data and were contacted by a case
manager before discharge. After the recruitment of patients to
the intervention arm, an active search for a matched control
with similar characteristics began. All patients and their carers,
regardless of study arm, received a face-to-face explanation
about the study.
Intervention
Patients in the intervention arm experienced an integrated care
model, including (i) preliminary assessment of the patient’s
health status using several questionnaires, tests, and indices
specific to their main chronic diseases and social needs; (ii) a
self-management app, with status and performance reports, a
virtual coach with customizable automated feedback, and full
communication with the care team; (iii) a Fitbit Flex 2 digital
activity tracker [10] and any additional sensor deemed necessary
by the care team [11], including a digital pulse-oximeter, digital
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scale, and digital blood pressure monitor, that were fully
integrated into the self-management app; (iv) a patient profile
in the SACM web-based platform, accessible to all members
of the care team (family physicians, hospital specialists, and
social workers), that was used for coordination and
communication among professionals in the different settings,
and to contact the patient when needed; and (v) assignment of
a case manager in charge of supervising the whole process and
serving as the main patient contact point. Additional details on
the CONNECARE integrated care model and the supporting
eHealth platform can be found in Multimedia Appendix 1.
Patients in the control arm experienced care as usual, managed
from primary care. After discharge from the initial 90 days of
usual care for integrated care management, all patients were
passively followed up for an additional 3 months.
Data Collection
Variables characterizing the patients were collected at
recruitment using the SACM in tablet or desktop computers,
including age, sex, main chronic disease(s), Charlson index of
comorbidities [12], quality of life (QoL) as measured by the
12-Item Short-Form Survey (SF-12) [13], Barthel index for
Activities of Daily Living [14], Hospital Anxiety and Depression
scale [15], assessment of dwelling characteristics, main
medications, Pfeiffer mental status questionnaire [16], and
tobacco and alcohol consumption. The main outcomes were:
(i) intervention effectiveness, as measured by the changes in
the SF-12 health questionnaire’s physical and mental domains
(baseline vs discharge); (ii) use of health care resources after 6
months, and estimated associated costs based on Catalan Health
Department official data [17]; and (iii) cost-effectiveness, based
on the improvement in QoL relative to costs, assessed by means
of the incremental cost-effectiveness ratio (ICER); all costs are
described in US $ (conversion factor: 1 € = 1.21 US $).
Additional details on cost estimations are described in
Multimedia Appendix 1. The use of health care resources was
collected from EMRs, which included hospital admissions, ER
visits, visits to primary care, and visits to hospital specialists.
Additionally, each admission or visit was assessed regarding
its relation to the patient’s chronic diseases as a binary variable
(related or unrelated).
Statistical Analyses
Participants’ baseline characteristics are summarized as n (%),
mean (SD), or median (IQR) as appropriate. Comparisons
between baseline characteristics of patients in the integrated
care and control groups were performed using the χ2 test, t test,
or Kruskal-Wallis test, as appropriate. A paired t test was used
to compare baseline to discharge values with respect to the
SF-12 domains. Linear regression models were used to assess
differences in the changes experienced by patients in the two
groups. Negative binomial regression models were used to
assess differences in the number of visits and admissions.
Models were adjusted by age, sex, and Charlson comorbidity
index. The ICER was calculated in relation to the SF-12 total
score in three different scenarios: 100%, 150%, and 200%
estimated cost of the integrated care program. Data analyses
were conducted using Stata version 12.1 (StataCorp, College
Station, TX, USA). The threshold for significance was P<.05.
Ethical Considerations
This study was approved by Ethics Committee of Hospital Arnau
de Vilanova (CEIC-1685) and all patients provided written
informed consent. All collected data were handled and stored
in accordance with current national and international legislation.
Results
Up to 112 patients were screened for eligibility. After excluding
patients not meeting the inclusion criteria, 52 patients were
recruited for the mHealth-enabled integrated care arm and 35
patients were recruited for the usual care arm. Final analyses
were based on 48 integrated care and 28 control patients
completing the follow up (Figure 1).
Figure 1. Study flowchart. EMR: electronic medical record.
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The patients’ baseline characteristics are shown in Table 1.
There were no significant differences in mean age or Charlson
index between the patients in the two arms.
Table 1. Baseline characteristics of patients in the usual care and integrated care (IC) arms.
P valueaIC (n=48)Usual care (n=28)Characteristic
.3724 (50)17 (61)Sex (male), n (%)
.8882 (7)82 (8)Age (years), mean (SD)
.156.7 (2.0)7.4 (2.1)Charlson score, mean (SD)
.3814 (12-17)15 (13-17)LACEb score, median (IQR)
.4090 (67.5-100)90 (72.5-95)Barthel score, median (IQR)
.444.3 (2.7)4.9 (3.5)HADc anxiety score, mean (SD)
.955.7 (2.3)5.6 (2.9)HAD depression score, mean (SD)
.6737 (77)21 (75)Pfeiffer intact intellectual functioning, n (%)
.2544 (92)27 (96)GDSd, no cognitive decline, n (%)
aχ2 test, t test, or Kruskal-Wallis equality-of-populations rank test, as appropriate.
bLACE: Length, Acuity, Comorbidities, and Emergency score.
cHAD: Hospital Anxiety and Depression scale.
dGDS: Global Deterioration Scale.
Table 2 shows the changes in QoL (SF-12 domains) from
baseline to discharge. Patients in the integrated care arm showed
a significant increase in the SF-12 physical domain and total
SF-12 scores. The differences in QoL between integrated care
and control patients favored the integrated care patients but did
not achieve statistical significance.
Table 2. Changes in health status in the usual care and integrated care arms.
P valuebChange, mean (SD)Discharge, mean (SD)Baseline, mean (SD)SF-12a score
Physical
.16+2.0 (7.5)31.6 (9.0)29.6 (8.3)Usual care
.004+3.7 (8.4)32.7 (9.4)29.0 (7.3)Integrated care
.21+1.7 (2.9)+1.1 (2.0)–0.6 (2.0)Difference
Mental
.59–1.2 (11.9)45.8 (15.5)47.0 (13.5)Usual care
.21+2.0 (11.2)53.9 (11.5)51.8 (9.9)Integrated care
.10+5.0 (5.2)+9.2 (3.7)+4.2 (3.7)Difference
Total
.77+0.8 (14.7)77.4 (20.5)76.6 (13.9)Usual care
.003+5.8 (12.8)86.6 (16.3)80.8 (11.9)Integrated care
.10+5.0 (5.2)+9.2 (3.7)+4.2 (3.7)Difference
aSF-12: 12-Item Short-Form Survey.
bPaired t test comparing baseline and discharge measures; linear regression predicting the difference on baseline and discharge measures according to
intervention arm, adjusted by age, sex, and Charlson index.
Table 3 shows that integrated care patients had 57% less
unplanned visits, representing a significant difference. Integrated
care patients also experienced a 50% reduction in hospital
admissions related to their main chronic diseases, although this
difference was not statistically significant.
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Table 3. Total use of health services during the follow-up period.
Adjusted P valuebP valueaIntegrated care (n=48),
mean (SD)
Usual care (n=28), mean
(SD)
Health service
.004.0011.0 (1.1)2.3 (3.1)All unplanned visits
.04.010.4 (0.6)0.9 (1.2)Unplanned visits related to chronic disease
.50.350.4 (0.6)0.5 (0.8)All hospital admissions
.32.180.2 (0.5)0.4 (0.7)Hospital admissions related to chronic
disease
aNegative binomial regression model.
bNegative binomial regression model adjusted by age, sex, and Charlson comorbidity index.
The results for the within trial costs and cost-effectiveness
analyses for all unplanned visits and hospital admissions are
shown in Table 4, and those for unplanned visits and hospital
admissions related to the patient’s main chronic diseases are
shown in Table S1 of Multimedia Appendix 1. The integrated
care program generated savings from US $584 to $1434 per
patient, depending on the scenarios. The integrated care program
was cost-effective according to the ICER, performing better in
terms of QoL while reducing overall expenses.
Table 4. Within trial costs (average cost per patient) and cost-effectiveness considering all unplanned visits and hospital admissions in three integrated
care (IC) program cost scenarios.
ICERaDifferenceIC (n=48), US $Usual care (n=28), US $Related cost
N/Ac–95.6078.02173.62Unplanned visitsb
N/A–665.792404.153069.94Hospital admissionsb
N/A–761.392482.173243.56Total medical costs per patient
Scenario 1: 100% IC program costs
N/A85.9285.920CONNECARE program
–135.64–675.472568.093243.56Total costs per patient
Scenario 2: 150% IC program costs
N/A128.89128.890CONNECARE program
–127.01–632.502611.063243.56Total costs per patient
Scenario 3: 200% IC program costs
171.84171.840CONNECARE program
–118.39–589.552654.013243.56Total costs per patient
aICER: incremental cost-effectiveness ratio; incremental cost associated with 1 additional point gain in 12-Item Short-Form Survey (SF-12).




The prospective assessment of the implementation of an
mHealth-enabled integrated care program for CCP management
showed a reduction in the number of unplanned contacts with
the health system, generated substantial savings for the health
system without having any negative impact on QoL or clinical
outcomes, and demonstrated cost-effectiveness.
Strengths and Limitations
A key strength of this study was the effort to involve, from the
very beginning, all of the stakeholders from different
organizations that would be actors in a large-scale deployment
of the mHealth-enabled integrated care program. This is
especially relevant as the lack of cooperation between
organizations, teams, or professions is a recurrent barrier toward
the implementation of integrated care [4]. Other relevant
strengths included: (i) the involvement of informal carers in the
integrated care process, as close relatives of patients are usually
the link between the patients and the health system, and such
informal carers were key for facilitating the use of the
self-management app in patients with a mean age over 80 years;
(ii) the use of a self-management app (including a virtual coach
with customizable automated feedback, full communication
with the care team, and active monitoring), as such apps can
significantly enhance doctor-patient relationships [18] and detect
worsening in patient conditions or frailty [19]; (iii) the
promotion and assessment of patients’ physical activity, as
mobility impairment is found in one third of people over 65
years [20]; (iii) the implementation region, a large rural area of
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over 4300 km2, which can benefit the most from
community-based integrated care initiatives that preclude
unnecessary travels to the hospital; and (iv) the prospective
study design.
In terms of limitations, although the organizational model did
not experience substantial changes throughout the
implementation period, the supporting technological platform
was in a permanent process of refinement and addition of new
functionalities. This implied that the integrated care experience
was richer in patients who were recruited near the end of the
implementation study compared with that of patients recruited
at the very beginning. Similarly, this had a considerable impact
on the health care professionals, who had to cope with a platform
in constant development and that was not fully integrated with
the existing EMR. However, directly participating in a dynamic
development and implementation process allowed the
professionals to feel engaged and propose changes, and for new
features to be developed, which ultimately resulted in not a
single professional dropping out of the implementation study.
Other limitations were: (i) the relatively small number of patients
involved in this first phase of the deployment, which ultimately
affected statistical power; (ii) the assumptions held while
determining the costs of the mHealth-enabled integrated care
program intervention, as well as the lack of assessment of
indirect (societal) savings; and (iii) the strategy of centralizing
the entry points to the integrated care program in the hospital
(after ER admission), as it is important that system-wide
cross-organizational care pathways consider multiple entry
points [21]. In this regard, upcoming phases of the
implementation will consider additional entry points such as
the primary care centers.
Comparison With Existing Literature
The impact of the implementation of the integrated care model
was assessed in three domains: (i) patients’ QoL, (ii) use of
health services, and (iii) economics. In the first domain, QoL,
the integrated care model performed slightly better than usual
care, with positive differences-in-differences values but not
reaching statistical significance. This result is in line with a
2017 umbrella review concluding that integrated care
interventions showed mixed results in terms of improving
patients’ QoL [22]. In this sense, it must be noted that the short
duration of the implemented intervention (3 months) could have
limited its capacity to affect the overall QoL. Nevertheless, the
short duration did not preclude obtaining excellent results in
terms of the use of health services. The integrated care model
reduced the number of unplanned visits by 57% and the number
of hospital admissions related to the main chronic disease of
each patient by 50%. Half of the published reviews on integrated
care interventions between 2000 and 2015 reported significant
reductions in hospital activity, ranging from 15% to 50% [23].
This places the reported results for the integrated care program
within the top margin of positive results, and supports the notion
of system-wide cross-organizational care pathways as a
successful way to implement integrated care in contrast to
smaller and narrow interventions [2]. Finally, regarding the
economic impact, integrated care generated savings from US
$584 to $1434 per patient and was cost-effective. This is in line
with reviews stating the potential cost-effectiveness of integrated
care for the management of chronic diseases [24]. Our results
are also in line with savings found in other chronic diseases
such as diabetes mellitus (from –1508 to +299 Euro;
approximately US $–1809 to +359) or schizophrenia (from
–3860 to +614 Euro; approximately US $–4632 to 737) [25].
Implications for Research and Practice
The need for people-centered integrated care, capable of
providing an adequate response to the needs of growing
populations of older people with chronic conditions while
keeping costs sustainable, has been clearly stated by the World
Health Organization [26]. In the frame of the CONNECARE
project, an mHealth-enabled integrated care model was
co-designed through an iterative process that involved all of the
key stakeholders: patients, hospital and primary care medical
and technical staff, social carers, managers, developers, and
researchers. This coproduction multidisciplinary team had a
clear focus on the patient and was ready to consider system-wide
cross-organizational care pathways. The resulting
mHealth-enabled integrated care model was thus perfectly
aligned with the 2015 World Health Organization report on
aging and health [1], which states that care providers should
ensure that: (i) the assessment of individual
impairments/declines in capacity is used to inform the
development of a comprehensive care plan, and all domains are
assessed together; (ii) interventions encouraging physical
exercise are included in the care plans; and (iii) the presence of
any impairment/decline in capacity triggers actions for the
medical assessment of associated diseases. Moreover, we
identified key features to be included in successful integrated
care models for elder CCP: (i) the involvement of informal
caregivers, being key in the adoption of mHealth tools such as
self-management apps and sensors, and making the overall user
experience very satisfactory [27]; (ii) the enablement of a
common web-based platform for the coordination of care across
settings and patient follow up; and (iii) the enhancement of
communication channels for patients, which reduced the need
of face-to-face appointments for quick consultations or
questions. This latter aspect is especially relevant when patients
are depending on others for travel to the general practitioners’
offices or primary care centers.
Conclusion
The implementation of a patient-centered mHealth-enabled
integrated care model empowering patients and connecting
primary, hospital, and social care professionals reduced
unplanned contacts with the health system and health costs, and
was cost-effective. This supports the notion of system-wide
cross-organizational care pathways using mHealth tools as a
successful way to implement integrated care.
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